A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, M. Goto, and T. Masaki A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
Selective endothelin a receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives
P.C. Astles, C. Brealey, T.J. Brown, V. Facchini, C. Handscombe, N.V. Harris, C. McCarty, I.M. McLay, B. Porter, A.G. Roach, C. Sargent, C. Smith, and R.J.A. Walsh Selective endothelin A receptor antagonists. 3. Discovery and structure-activity relationships of a series of 4-phenoxybutanoic acid derivatives J. Med. Chem. 41 1998 2732 2744
Thieno[2,3-d]pyrimidine-3-acetic acids. a new class of nonpeptide endothelin receptor antagonists
N. Cho, Y. Nara, M. Harada, T. Sugo, Y. Masuda, A. Abe, K. Kusumoto, Y. Itoh, T. Watanabe, and S. Furuya Thieno[2,3-d]pyrimidine-3-acetic acids. A new class of nonpeptide endothelin receptor antagonists Chem. Pharm. Bull. 46 1998 1724 1737
Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist
C. Wu, M.F. Chan, F. Stavros, B. Raju, I. Okun, S. Mong, K.M. Keller, T. Brock, T.P. Kogan, and R.A.F. Dixon Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist J. Med. Chem. 40 1997 1690 1697
Heterocycles from CH-acidic nitriles. VIII. 2-Aminothiophenes from methylene-active nitriles, carbonyl compounds, and sulfur
K. Gewald, E. Schinke, and H. Böttcher Heterocycles from CH-acidic nitriles. VIII. 2-Aminothiophenes from methylene-active nitriles, carbonyl compounds, and sulfur Chem. Ber. 99 1966 94 100
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B
H.S. Andersen, O.H. Olsen, L.F. Iversen, A.L.P. Sorensen, S.B. Mortensen, M.S. Christensen, S. Branner, T.K. Hansen, J.F. Lau, L. Jeppesen, E.J. Moran, J. Su, F. Bakir, L. Judge, M. Shahbaz, T. Collins, T. Vo, M.J. Newman, W.C. Ripka, and N.P.H. Moller Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B J. Med. Chem. 45 2002 4443 4459
M. Modica, M. Palkó, G. Romeo, L. Materia, F. Russo, and F. Fülöp Synthesis of novel potential selective 5-HT3 receptor ligands, XXI European Colloquium on Heterocyclic Chemistry. Sopron, Hungary, September 12-15 TP-16 2004
Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors
P. Nambi, N. Elshourbagy, H.L. Wu, M. Pullen, E.H. Ohlstein, D.P. Brooks, M.A. Lago, J.D. Elliott, J.G. Gleason, and R.R. Ruffolo Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors J. Pharmacol. Exp. Ther. 271 1994 755 761
Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological dose-response curves
A. De Lean, P.J. Munson, and D. Rodbard Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay and physiological dose-response curves Am. J. Physiol. 235 1978 E97 E102